[ad_1]
“We are actively investing in innovation and firmly believe that by strengthening Abu Dhabi’s national life sciences ecosystem, we are building a future-proof, sustainable and knowledge-based economy for the UAE,” said Badr Al- Olama said. Mubadala platform. “Through this agreement, Mubadala and its group of companies will unlock further growth opportunities within the life sciences ecosystem and, together with our key partners, will play an important role in establishing a state-of-the-art biopharmaceutical park to Securing supply chains from Abu Dhabi in the region.”
The partnership with Resilience also follows the recent announcement that Mubadala Health and G42 Healthcare have joined forces to form a new, first-of-its-kind integrated healthcare technology company.
National Resilience, a well-known biotechnology company headquartered in California, USA, is building a network of high-tech, end-to-end manufacturing solutions designed to ensure that existing and future needs of complex drugs are met quickly, safely and at scale. The US-based company will provide manufacturing, technical and operational expertise at the Abu Dhabi facility, integrating it as a node in a global network of facilities.
[ad_2]
Source link
